1. Home
  2. CGON vs RUM Comparison

CGON vs RUM Comparison

Compare CGON & RUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • RUM
  • Stock Information
  • Founded
  • CGON 2010
  • RUM 2013
  • Country
  • CGON United States
  • RUM United States
  • Employees
  • CGON N/A
  • RUM N/A
  • Industry
  • CGON
  • RUM Computer Software: Prepackaged Software
  • Sector
  • CGON
  • RUM Technology
  • Exchange
  • CGON NYSE
  • RUM Nasdaq
  • Market Cap
  • CGON 2.3B
  • RUM 2.6B
  • IPO Year
  • CGON 2024
  • RUM N/A
  • Fundamental
  • Price
  • CGON $27.85
  • RUM $10.50
  • Analyst Decision
  • CGON Strong Buy
  • RUM Buy
  • Analyst Count
  • CGON 10
  • RUM 3
  • Target Price
  • CGON $65.11
  • RUM $14.00
  • AVG Volume (30 Days)
  • CGON 430.1K
  • RUM 3.3M
  • Earning Date
  • CGON 03-04-2025
  • RUM 03-26-2025
  • Dividend Yield
  • CGON N/A
  • RUM N/A
  • EPS Growth
  • CGON N/A
  • RUM N/A
  • EPS
  • CGON N/A
  • RUM N/A
  • Revenue
  • CGON $684,000.00
  • RUM $85,651,775.00
  • Revenue This Year
  • CGON $158.34
  • RUM $18.52
  • Revenue Next Year
  • CGON N/A
  • RUM $21.18
  • P/E Ratio
  • CGON N/A
  • RUM N/A
  • Revenue Growth
  • CGON 258.12
  • RUM 6.36
  • 52 Week Low
  • CGON $25.77
  • RUM $4.92
  • 52 Week High
  • CGON $47.78
  • RUM $17.40
  • Technical
  • Relative Strength Index (RSI)
  • CGON 41.49
  • RUM 40.23
  • Support Level
  • CGON $27.10
  • RUM $10.52
  • Resistance Level
  • CGON $29.42
  • RUM $12.15
  • Average True Range (ATR)
  • CGON 1.15
  • RUM 0.84
  • MACD
  • CGON -0.10
  • RUM -0.25
  • Stochastic Oscillator
  • CGON 29.02
  • RUM 1.19

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About RUM Rumble Inc.

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: